These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17655376)

  • 1. Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris.
    Thiboutot DM; Willmer J; Sharata H; Halder R; Garrett S
    Clin Pharmacokinet; 2007; 46(8):697-712. PubMed ID: 17655376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris.
    Jarratt MT; Jones TM; Chang-Lin JE; Tong W; Berk DR; Lin V; Kaoukhov A
    J Drugs Dermatol; 2016 Oct; 15(10):1250-1259. PubMed ID: 27741344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Dapsone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Dapsone 5% Gel Combination Treatment.
    Kircik LH
    J Drugs Dermatol; 2016 Feb; 15(2):191-5. PubMed ID: 26885787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.
    Stotland M; Shalita AR; Kissling RF
    Am J Clin Dermatol; 2009; 10(4):221-7. PubMed ID: 19489655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment.
    Lucky AW; Maloney JM; Roberts J; Taylor S; Jones T; Ling M; Garrett S;
    J Drugs Dermatol; 2007 Oct; 6(10):981-7. PubMed ID: 17966175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of dapsone gel 5% in the treatment of acne vulgaris.
    Pickert A; Raimer S
    Expert Opin Pharmacother; 2009 Jun; 10(9):1515-21. PubMed ID: 19505219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.
    Draelos ZD; Carter E; Maloney JM; Elewski B; Poulin Y; Lynde C; Garrett S;
    J Am Acad Dermatol; 2007 Mar; 56(3):439.e1-10. PubMed ID: 17208334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials.
    Stein Gold LF; Jarratt MT; Bucko AD; Grekin SK; Berlin JM; Bukhalo M; Weiss JS; Berk DR; Chang-Lin JE; Lin V; Kaoukhov A
    J Drugs Dermatol; 2016 May; 15(5):553-61. PubMed ID: 27168264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials.
    Eichenfield LF; Lain T; Frankel EH; Jones TM; Chang-Lin JE; Berk DR; Ruan S; Kaoukhov A
    J Drugs Dermatol; 2016 Aug; 15(8):962-9. PubMed ID: 27537997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.
    Piette WW; Taylor S; Pariser D; Jarratt M; Sheth P; Wilson D
    Arch Dermatol; 2008 Dec; 144(12):1564-70. PubMed ID: 19075138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy and Safety of Topical Dapsone Gel, 5% for the Treatment of Acne Vulgaris in Adult Females With Skin of Color.
    Alexis AF; Burgess C; Callender VD; Herzog JL; Roberts WE; Schweiger ES; Stockton TC; Gallagher CJ
    J Drugs Dermatol; 2016 Feb; 15(2):197-204. PubMed ID: 26885788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Experience With Once-Daily Dapsone Gel, 7.5% Monotherapy in Patients With Acne Vulgaris.
    Stockton TC; Tanghetti EA; Lain E; Zeichner JA; Alvandi N
    J Drugs Dermatol; 2018 Jun; 17(6):602-608. PubMed ID: 29879247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapsone 7.5% Gel: A Review in Acne Vulgaris.
    Al-Salama ZT; Deeks ED
    Am J Clin Dermatol; 2017 Feb; 18(1):139-145. PubMed ID: 28005194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents.
    Raimer S; Maloney JM; Bourcier M; Wilson D; Papp K; Siegfried E; Garrett S;
    Cutis; 2008 Feb; 81(2):171-8. PubMed ID: 18441772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
    Tanghetti E; Dhawan S; Green L; Ling M; Downie J; Germain MA; Kasteler JS; Kircik L; Oefelein MG; Draelos Z
    J Drugs Dermatol; 2011 Jul; 10(7):783-92. PubMed ID: 21720661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Pharmacokinetics, Safety and Exploratory Efficacy Study of a Topical Bactericidal VB-1953: Analysis of Single and Multiple Doses in a Phase I Trial in Acne Vulgaris Subjects.
    Jain S; Yadav V; Bhatia N
    Clin Drug Investig; 2020 Mar; 40(3):259-268. PubMed ID: 31927743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
    Yu Z; Sefton J; Lew-Kaya D; Walker P; Yu D; Tang-Liu DD
    Clin Pharmacokinet; 2003; 42(10):921-9. PubMed ID: 12885265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype.
    Taylor SC; Cook-Bolden FE; McMichael A; Downie JB; Rodriguez DA; Alexis AF; Callender VD; Alvandi N
    J Drugs Dermatol; 2018 Feb; 17(2):160-167. PubMed ID: 29462223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aczone, a topical gel formulation of the antibacterial, anti-inflammatory dapsone for the treatment of acne.
    Scheinfeld N
    Curr Opin Investig Drugs; 2009 May; 10(5):474-81. PubMed ID: 19431080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable.
    Tanghetti E; Harper JC; Oefelein MG
    J Drugs Dermatol; 2012 Dec; 11(12):1417-21. PubMed ID: 23377510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.